Search

Search Constraints

You searched for: Author/Creator Cedrone, Michele

Search Results

1. Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients. Issue 10 (October 2015)

2. Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1‐negative Myeloproliferative Neoplasms Latium Group". (16th June 2020)

3. Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia. Issue 13 (10th November 2019)

4. Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase. (18th September 2015)

5. Dasatinib first-line: Multicentric Italian experience outside clinical trials. (January 2016)

6. Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosis. Issue 3 (March 2015)

7. High platelet count at diagnosis is a protective factor for thrombosis in patients with essential thrombocythemia. Issue 156 (August 2017)

8. Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus ALL study. (6th November 2022)

9. Prognostic factors for thrombosis-free survival and overall survival in polycythemia vera: A retrospective analysis of 623 PTS With long follow-up. (June 2018)

10. Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia. (23rd May 2017)